XML 30 R19.htm IDEA: XBRL DOCUMENT v3.25.2
SHAREHOLDERS' EQUITY
6 Months Ended
Jun. 30, 2025
SHAREHOLDERS' EQUITY  
SHAREHOLDERS' EQUITY

NOTE 13 – SHAREHOLDERS’ EQUITY

In January and February 2025, certain investors in the December 2024 Offering exercised (i) the remaining outstanding 320,362 December 2024 Pre-Funded Warrants, (ii) 9,143 Series F Warrants and 3,000 Series G Warrants, resulting in net proceeds to the Company of approximately $173,000.

Warrants

The following table summarizes warrant activities during the six months ended June 30, 2025:

    

    

Weighted

ADSs

Average

Underlying

Exercise Price

Warrants

Per ADS

Outstanding and exercisable at December 31, 2024

1,440,664

 

$

16.80

Exercised Pre-Funded and Common Warrants

 

(332,505)

0.58

Outstanding and exercisable at June 30, 2025

1,108,159

$

21.92

As of June 30, 2025, outstanding Warrants expire in 2026, 2027 and 2029, and the outstanding Warrants have an approximate intrinsic value of $0.